Le Lézard
Classified in: Health
Subjects: PDT, SCZ

Promising Early Results from Using imp's Landline Call Screening Technology as an Alzheimer's and Dementia Phone Solution


100% of caregivers report an improvement in their AND their parent's, lives after deploying imptm, a smart home solution that eliminates ALL unwanted landline phone calls.

ETNA, N.H., Jan. 5, 2023 /PRNewswire/ -- Landline phones pose a unique challenge to aging Americans and their caregivers. The phone helps maintain connections to family, friends, and the community. It is a symbol of independence, and a familiar marker of continuity. But, in 2021, almost $5 billion dollars was stolen, largely from seniors, through landline phone fraud.

For the 48 million senior Americans over 65 with landlines, for the 6 million seniors who have Alzheimer's, and for the 11 million caregivers, an Alzheimer's and dementia phone solution is needed. Early results show that imptm can help.

Caregivers of seniors with Alzheimer's or dementia are increasingly relying on imp as an essential tool in their care management process. For the caregiver, imp provides remote management and 100% control over who can call. For the senior parent, imp transforms their phone, making every call a wanted call.

A survey of 15 caregivers provided the following insights: 

Based on these strong initial results, imp is launching a free six-month, nationwide research program on the impact of imp on the lives of Seniors and their caregivers. Research will include pre- and post-installation surveys, quality of life measurements, and longer-term impact analysis. Requirements include: a landline, Caller ID, and a Wi-Fi connection to the internet. Caregivers need to have a smartphone. Contact [email protected] for more details.

About imp

Founded in 2019 in New Hampshire, imp's mission is to rid the world of the scourge of the unwanted landline caller. The team consists of old-school landline experts, modern smartphone developers, and network security and privacy architects. Learn more at joinimp.com

Media Contact:
George Lightbody
1-800-374-0056
[email protected] 

SOURCE imp


These press releases may also interest you

at 13:30
XyloCor Therapeutics, Inc., a clinical?stage biopharmaceutical company developing novel gene therapies for cardiovascular disease, today presented final results from the Phase 2 portion of its Phase 1/2 clinical trial (EXACT) of its lead gene therapy...

at 13:25
Kamut International founder and regenerative organic agriculture visionary Dr. Robert "Bob" M. Quinn unveils an unprecedented initiative with the launch of Quinn Institute, a groundbreaking research and demonstration hub designed to foster the...

at 13:24
PMB is proud to announce the opening of the University of Chicago Medicine's new 132,000-square-foot multispecialty care center in Northwest Indiana, bringing academic medicine-level care to the area's growing community. The ribbon-cutting ceremony...

at 13:11
Jones Walker LLP is pleased to welcome Greg Schafer and Valerie Fontenot as special counsel in the firm's Litigation Practice Group and members of the firm's growing Healthcare Industry Team in the New Orleans office....

at 13:05
Mammoth Biosciences, a biotechnology company harnessing its proprietary next-generation CRISPR gene-editing platform to create potential one-time curative therapies, today announced that Lucas Harrington, Ph.D., Mammoth's co-founder and Chief...

at 13:00
Patients with liver cancer in the southeast can stay closer to home and trust they'll receive the latest, most advanced care as Northeast Georgia Medical Center (NGMC) recently completed the first histotripsy procedure in the state of Georgia....



News published on and distributed by: